Denmark vs Iceland: Incidence of tuberculosis
Incidence of tuberculosis over time
- Denmark
- Iceland
How they compare
Denmark currently reports 3.2 per 100,000 people against 3 per 100,000 people in Iceland, a difference of 0.2 per 100,000 people.
That makes Denmark's figure about 1.1 times Iceland's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Denmark ahead.
Denmark ranks 188th and Iceland ranks 191st of 208 countries.
Denmark has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.03 per 100,000 people | 3.34 per 100,000 people | 6.69 per 100,000 people | Denmark |
| 2010s | 6.77 per 100,000 people | 3.19 per 100,000 people | 3.58 per 100,000 people | Denmark |
| 2020s | 3.84 per 100,000 people | 3.2 per 100,000 people | 0.64 per 100,000 people | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Denmark or Iceland?
- Denmark, at 3.2 per 100,000 people against 3 per 100,000 people in Iceland as of 2024.
- What is the difference in incidence of tuberculosis between Denmark and Iceland?
- 0.2 per 100,000 people, with Denmark ahead.
- How many years of comparable data are there for Denmark and Iceland?
- 25 years are reported by both, from 2000 to 2024.
- How do Denmark and Iceland rank globally for incidence of tuberculosis?
- Denmark ranks 188th and Iceland ranks 191st of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.